An interventional study of ACP GAME and acp manual in Advanced Care Planning (ACP), ELDERLY PEOPLE and Lung Cancer (NSCLC), sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 46 studies in Lung Neoplasms by National Taiwan University Hospital — 12 open to participants now, 12 under way, 1 of them phase 3. Lung Neoplasms · National Taiwan University Hospital.
Among the 46 studies in Lung Neoplasms by National Taiwan University Hospital, this one is the 8th largest by enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2024, is one of 16 with no phase, and was the 40th registered.
5,436 studies on the registry are indexed under Lung Neoplasms; 1,350 are open to participants now.
Browse Lung Neoplasms studies →12 of the 46 studies in Lung Neoplasms by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:
National Taiwan University Hospital · Sites in Taiwan
Ages 18+
National Taiwan University Hospital · Sites in Taiwan
Ages 18–80
National Taiwan University Hospital · Sites in Taiwan
Ages 20–90
National Taiwan University Hospital · Sites in Taiwan
Ages 20+
National Taiwan University Hospital · Sites in Taiwan
Ages 20+ · Healthy volunteers
By country, each count listing its studies:
Of the 997 Lung Neoplasms studies recruiting now, 686 (69%) set no upper age limit and 143 (14%) stop at 75 or younger; 45 take children under 18; 143 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
46 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 2
First in 2004; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 124 is above the median of 60 across 3,668 interventional studies indexed under Lung Neoplasms.
Median enrollment 103 across the 20 interventional studies, 131 across the 26 observational. Of the 13 that completed or were terminated, 2 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
National Taiwan University Hospital is the lead sponsor of 2,617 studies on the registry; 575 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.
3 of the studies in Lung Neoplasms by National Taiwan University Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07434167National Taiwan University HospitalExtended Reality (XR)-Assisted CT Localization of Pulmonary Nodules | 2026-12 |
| NCT07436598National Taiwan University Hospital3D Virtual Resection for Predicting Lung Function in VATS | 2027-06-30 |
| NCT07045610National Taiwan University HospitalPrimary Resistance Mechanisms of ALK TKIs | 2027-07-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 46 studies in Lung Neoplasms by National Taiwan University Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial examined whether an advance care planning (ACP) tabletop game ("Walking with Wishes") could improve the consistency of life-sustaining treatment preferences between older adults with lung cancer and their potential surrogates (family members or friends), compared to a standard ACP manual. Eligible dyads (patient-surrogate pairs) were randomized 1:1 to either the tabletop game intervention or the ACP manual control group. The primary outcome was the absolute gap score on the modified Life Support Preferences Questionnaire (m-LSPQ), measuring the difference between patient and surrogate preferences for five life-sustaining treatments (antibiotics, CPR, surgery, nasogastric tube feeding, and intravenous infusion) across nine health scenarios. Secondary outcomes included state anxiety (STAI-S) for both patients and surrogates. The m-LSPQ was assessed at baseline (T0), 2 weeks (T2), and 6 weeks (T3) post-intervention. The STAI-S was additionally assessed immediately post-intervention (T1) to capture acute emotional responses to the intervention.
The criteria were revised on the registry on Oct 30, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
,Using board games as an activity intervention, a tool for discussion between elderly people with lung cancer and potential agents
Behavioral: ACP GAME
Behavioral: acp manual
,Using board games as an activity intervention, a tool for discussion between elderly people with lung cancer and potential agents
acp manual
Absolute Gap Score on m-LSPQ Total Score Baseline
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. The absolute gap score is calculated within each patient-surrogate dyad as \|surrogate total score - patient total score\|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Time frame: Baseline (T0)
Absolute Gap Score on m-LSPQ Total Score at 2 Weeks
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate a greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. For each patient-surrogate dyad, the absolute gap score is calculated as \|surrogate total score - patient total score\|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Time frame: 2 weeks post-intervention (T2)
Absolute Gap Score on m-LSPQ Total Score at 6 Weeks
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate a greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. For each patient-surrogate dyad, the absolute gap score is calculated as \|surrogate total score - patient total score\|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Time frame: 6 weeks post-intervention (T3)
State Anxiety (STAI-S) of Patients (T0)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It includes 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety.
Time frame: Baseline (T0)
State Anxiety (STAI-S) of Patients (T1)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current (state) anxiety. It includes 20 items and yields a total score range of 20 to 80; higher scores indicate higher anxiety. Scores are reported as mean (standard deviation) for patients at the specified time point.
Time frame: Immediately post-intervention (T1)
State Anxiety (STAI-S) of Patients (T2)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for patients at 2 weeks post-intervention.
Time frame: 2 weeks post-intervention (T2)
State Anxiety (STAI-S) of Patients (T3)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for patients at 6 weeks post-intervention.
Time frame: 6 weeks post-intervention (T3)
State Anxiety (STAI-S ) of Surrogates (T0)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for surrogates at baseline.
Time frame: Baseline (T0)
State Anxiety (STAI-S ) of Surrogates (T1)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for surrogates immediately post-intervention.
Time frame: immediately post-intervention (T1)
State Anxiety (STAI-S ) of Surrogates (T2)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current (state) anxiety. It includes 20 items and yields a total score range of 20 to 80; higher scores indicate higher anxiety. Scores are reported as mean (standard deviation) for surrogates at the specified time point.
Time frame: 2 weeks post-intervention (T2)
State Anxiety (STAI-S ) of Surrogates (T3)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current (state) anxiety. It includes 20 items and yields a total score range of 20 to 80; higher scores indicate higher anxiety. Scores are reported as mean (standard deviation) for surrogates at the specified time point.
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Antibiotics Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 (absolutely unwanted) to 5 (absolutely wanted). The antibiotics subscale includes 9 items, with total scores ranging from 9 to 45. Higher scores indicate a greater preference for receiving antibiotics. Patient and surrogate subscale scores are reported separately. For each patient-surrogate dyad, the absolute gap score was calculated as \|surrogate score - patient score\|. Gap scores range from 0 to 36; smaller scores indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Time frame: Baseline (T0)
Absolute Gap in Antibiotics Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 (absolutely unwanted) to 5 (absolutely wanted). The antibiotics subscale includes 9 items, with total scores ranging from 9 to 45. Higher scores indicate a greater preference for receiving antibiotics. Patient and surrogate subscale scores are reported separately. For each patient-surrogate dyad, the absolute gap score was calculated as \|surrogate score - patient score\|. Gap scores range from 0 to 36; smaller scores indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Antibiotics Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The antibiotics subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving antibiotics as a life-sustaining treatment. The absolute gap score for antibiotics preference was calculated as \|Surrogate antibiotics subscale score - Patient antibiotics subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Cardiopulmonary Resuscitation (CPR) Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The cardiopulmonary resuscitation (CPR) subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving CPR as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate CPR subscale score - Patient CPR subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: Baseline (T0)
Absolute Gap in Cardiopulmonary Resuscitation (CPR) Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The cardiopulmonary resuscitation (CPR) subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving CPR as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate CPR subscale score - Patient CPR subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Cardiopulmonary Resuscitation (CPR) Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The cardiopulmonary resuscitation (CPR) subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving CPR as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate CPR subscale score - Patient CPR subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Surgery Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The surgery subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving surgery as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate surgery subscale score - Patient surgery subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: Baseline (T0)
Absolute Gap in Surgery Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The surgery subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving surgery as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate surgery subscale score - Patient surgery subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Surgery Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The surgery subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving surgery as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate surgery subscale score - Patient surgery subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Nasogastric Tube Feeding (NG) Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The nasogastric tube feeding subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving nasogastric tube feeding as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate NG tube feeding subscale score - Patient NG tube feeding subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: Baseline (T0)
Absolute Gap in Nasogastric Tube Feeding (NG) Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The nasogastric tube feeding subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving nasogastric tube feeding as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate NG tube feeding subscale score - Patient NG tube feeding subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Nasogastric Tube Feeding (NG) Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The nasogastric tube feeding subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving nasogastric tube feeding as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate NG tube feeding subscale score - Patient NG tube feeding subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Intravenous Infusion (IV) Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The intravenous infusion subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving intravenous infusion as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate intravenous infusion subscale score - Patient intravenous infusion subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: Baseline (T0)
Absolute Gap in Intravenous Infusion (IV) Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The intravenous infusion subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving intravenous infusion as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate intravenous infusion subscale score - Patient intravenous infusion subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Intravenous Infusion (IV) Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The intravenous infusion subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving intravenous infusion as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate intravenous infusion subscale score - Patient intravenous infusion subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Time frame: 6 weeks post-intervention (T3)
98 dyads screened; 36 declined. 62 dyads (124 individuals) randomized 1:1 to tabletop game vs ACP manual. Flow counts are individuals, not dyads.
| Milestone | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Started | 62 | 62 |
| Completed | 58 | 56 |
| Not completed | 4 | 6 |
| Withdrew: Withdrawal by subject | 4 | 0 |
| Withdrew: Death | 0 | 2 |
| Withdrew: Worsening condition | 0 | 4 |
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. The absolute gap score is calculated within each patient-surrogate dyad as \|surrogate total score - patient total score\|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient total m-LSPQ score | 112.59 ± 44.69 | 112.74 ± 40.96 |
| Surrogate total m-LSPQ score | 134.17 ± 41.81 | 136.84 ± 49.84 |
| Absolute gap |Surrogate-Patient| | 48.90 ± 17.62 | 48.77 ± 28.68 |
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It includes 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| State Anxiety (STAI-S) of Patients (T0) | 36.38 ± 9.28 | 34.81 ± 11.49 |
The State-Trait Anxiety Inventory-State (STAI-S) assesses current (state) anxiety. It includes 20 items and yields a total score range of 20 to 80; higher scores indicate higher anxiety. Scores are reported as mean (standard deviation) for patients at the specified time point.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| State Anxiety (STAI-S) of Patients (T1) | 34.17 ± 7.44 | 33.97 ± 8.45 |
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for patients at 2 weeks post-intervention.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| State Anxiety (STAI-S) of Patients (T2) | 37.00 ± 11.23 | 36.35 ± 10.50 |
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for patients at 6 weeks post-intervention.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| State Anxiety (STAI-S) of Patients (T3) | 38.14 ± 10.79 | 35.75 ± 10.57 |
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for surrogates at baseline.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| State Anxiety (STAI-S ) of Surrogates (T0) | 36.03 ± 10.68 | 36.39 ± 11.56 |
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for surrogates immediately post-intervention.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| State Anxiety (STAI-S ) of Surrogates (T1) | 33.38 ± 8.61 | 34.45 ± 9.53 |
The State-Trait Anxiety Inventory-State (STAI-S) assesses current (state) anxiety. It includes 20 items and yields a total score range of 20 to 80; higher scores indicate higher anxiety. Scores are reported as mean (standard deviation) for surrogates at the specified time point.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| State Anxiety (STAI-S ) of Surrogates (T2) | 37.48 ± 11.57 | 35.84 ± 10.60 |
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate a greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. For each patient-surrogate dyad, the absolute gap score is calculated as \|surrogate total score - patient total score\|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient total m-LSPQ score | 122.14 ± 45.04 | 108.55 ± 43.06 |
| Surrogate total m-LSPQ score | 126.93 ± 44.10 | 134.39 ± 47.25 |
| Absolute gap |Surrogate-Patient| | 49.34 ± 26.30 | 43.03 ± 31.06 |
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate a greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. For each patient-surrogate dyad, the absolute gap score is calculated as \|surrogate total score - patient total score\|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient total m-LSPQ score | 117.28 ± 44.17 | 101.86 ± 37.73 |
| Surrogate total m-LSPQ score | 130.66 ± 48.10 | 129.43 ± 41.77 |
| Absolute gap |Surrogate-Patient| | 39.17 ± 20.50 | 46.32 ± 28.18 |
The State-Trait Anxiety Inventory-State (STAI-S) assesses current (state) anxiety. It includes 20 items and yields a total score range of 20 to 80; higher scores indicate higher anxiety. Scores are reported as mean (standard deviation) for surrogates at the specified time point.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| State Anxiety (STAI-S ) of Surrogates (T3) | 37.31 ± 10.96 | 32.82 ± 8.17 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 (absolutely unwanted) to 5 (absolutely wanted). The antibiotics subscale includes 9 items, with total scores ranging from 9 to 45. Higher scores indicate a greater preference for receiving antibiotics. Patient and surrogate subscale scores are reported separately. For each patient-surrogate dyad, the absolute gap score was calculated as \|surrogate score - patient score\|. Gap scores range from 0 to 36; smaller scores indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient Antibiotics score | 28.72 ± 11.59 | 28.42 ± 10.54 |
| Surrogate Antibiotics score | 32.59 ± 9.11 | 31.13 ± 11.29 |
| Absolute gap |Surrogate-Patient| | 10.48 ± 6.10 | 9.77 ± 6.99 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 (absolutely unwanted) to 5 (absolutely wanted). The antibiotics subscale includes 9 items, with total scores ranging from 9 to 45. Higher scores indicate a greater preference for receiving antibiotics. Patient and surrogate subscale scores are reported separately. For each patient-surrogate dyad, the absolute gap score was calculated as \|surrogate score - patient score\|. Gap scores range from 0 to 36; smaller scores indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient Antibiotics score | 30.38 ± 10.47 | 26.74 ± 10.16 |
| Surrogate Antibiotics score | 30.24 ± 9.96 | 32.71 ± 10.27 |
| Absolute gap |Surrogate-Patient| | 10.00 ± 8.62 | 8.71 ± 7.51 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The antibiotics subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving antibiotics as a life-sustaining treatment. The absolute gap score for antibiotics preference was calculated as \|Surrogate antibiotics subscale score - Patient antibiotics subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient Antibiotics score | 29.38 ± 11.19 | 26.29 ± 9.93 |
| Surrogate Antibiotics score | 29.55 ± 10.16 | 31.86 ± 10.79 |
| Absolute gap |Surrogate-Patient| | 6.59 ± 5.82 | 10.07 ± 7.38 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The cardiopulmonary resuscitation (CPR) subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving CPR as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate CPR subscale score - Patient CPR subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient CPR score | 17.55 ± 9.08 | 17.81 ± 9.08 |
| Surrogate CPR score | 23.59 ± 10.16 | 23.52 ± 11.38 |
| Absolute gap |Surrogate-Patient| | 8.52 ± 5.40 | 9.10 ± 7.60 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The cardiopulmonary resuscitation (CPR) subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving CPR as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate CPR subscale score - Patient CPR subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient CPR score | 18.59 ± 9.96 | 17.45 ± 9.24 |
| Surrogate CPR score | 21.90 ± 10.53 | 23.52 ± 11.51 |
| Absolute gap |Surrogate-Patient| | 8.72 ± 6.63 | 7.61 ± 6.70 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The cardiopulmonary resuscitation (CPR) subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving CPR as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate CPR subscale score - Patient CPR subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient CPR score | 17.07 ± 8.96 | 17.96 ± 9.51 |
| Surrogate CPR score | 22.52 ± 10.72 | 24.75 ± 11.69 |
| Absolute gap |Surrogate-Patient| | 7.17 ± 4.33 | 9.61 ± 7.68 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The surgery subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving surgery as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate surgery subscale score - Patient surgery subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient surgery score | 22.45 ± 10.63 | 23.35 ± 10.07 |
| Surrogate surgery score | 27.34 ± 9.72 | 27.48 ± 10.82 |
| Absolute gap |Surrogate-Patient| | 9.28 ± 3.47 | 10.19 ± 5.46 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The surgery subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving surgery as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate surgery subscale score - Patient surgery subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient Surgery score | 23.03 ± 10.69 | 22.35 ± 9.87 |
| Surrogate Surgery score | 25.62 ± 10.14 | 25.65 ± 10.53 |
| Absolute gap |Surrogate-Patient| | 10.48 ± 6.17 | 8.58 ± 6.29 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The surgery subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving surgery as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate surgery subscale score - Patient surgery subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient Surgery score | 21.14 ± 10.32 | 20.57 ± 9.24 |
| Surrogate Surgery score | 25.17 ± 10.49 | 25.25 ± 10.16 |
| Absolute gap |Surrogate-Patient| | 9.66 ± 6.96 | 9.21 ± 5.93 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The nasogastric tube feeding subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving nasogastric tube feeding as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate NG tube feeding subscale score - Patient NG tube feeding subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient NG Tube Feeding score | 17.48 ± 9.51 | 17.48 ± 8.86 |
| Surrogate NG Tube Feeding score | 24.14 ± 10.38 | 24.06 ± 10.72 |
| Absolute gap |Surrogate-Patient| | 10.59 ± 7.72 | 9.94 ± 6.66 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The nasogastric tube feeding subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving nasogastric tube feeding as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate NG tube feeding subscale score - Patient NG tube feeding subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient NG Tube Feeding score | 18.10 ± 9.87 | 17.97 ± 9.24 |
| Surrogate NG Tube Feeding score | 23.41 ± 10.84 | 24.32 ± 10.16 |
| Absolute gap |Surrogate-Patient| | 9.52 ± 8.71 | 7.60 ± 6.51 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The nasogastric tube feeding subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving nasogastric tube feeding as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate NG tube feeding subscale score - Patient NG tube feeding subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient NG Tube Feeding score | 17.21 ± 9.51 | 16.96 ± 8.64 |
| Surrogate NG Tube Feeding score | 22.76 ± 10.63 | 22.82 ± 10.05 |
| Absolute gap |Surrogate-Patient| | 8.55 ± 5.90 | 7.96 ± 6.32 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The intravenous infusion subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving intravenous infusion as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate intravenous infusion subscale score - Patient intravenous infusion subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient Intravenous Infusion score | 25.97 ± 10.53 | 26.06 ± 10.16 |
| Surrogate Intravenous Infusion score | 28.59 ± 9.24 | 28.65 ± 10.47 |
| Absolute gap |Surrogate-Patient| | 10.02 ± 6.50 | 9.77 ± 6.71 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The intravenous infusion subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving intravenous infusion as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate intravenous infusion subscale score - Patient intravenous infusion subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient Intravenous Infusion score | 26.90 ± 10.38 | 25.58 ± 9.72 |
| Surrogate Intravenous Infusion sc | 28.41 ± 9.51 | 28.32 ± 10.63 |
| Absolute gap |Surrogate-Patient| | 10.62 ± 6.59 | 9.42 ± 7.51 |
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The intravenous infusion subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving intravenous infusion as a life-sustaining treatment. The absolute gap score was calculated as \|Surrogate intravenous infusion subscale score - Patient intravenous infusion subscale score\|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
| scores on a scale | Experimental: ACP Tabletop Game | Control: ACP Manual |
|---|---|---|
| Patient Intravenous Infusion score | 25.97 ± 10.16 | 24.46 ± 9.24 |
| Surrogate Intravenous Infusion score | 28.48 ± 9.87 | 28.68 ± 10.38 |
| Absolute gap |Surrogate-Patient| | 7.21 ± 6.13 | 9.46 ± 6.99 |
Collected over From enrollment (baseline assessment) through 6 weeks post-intervention follow-up.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| ACP Tabletop Game | 0/29 (0%) | 0/29 (0%) | 0/29 (0%) |
| ACP Manual | 1/31 (3.2%) | 0/31 (0%) | 0/31 (0%) |
Baseline characteristics are reported for individual participants (patients and surrogates). Randomization occurred at the dyad level. The 4 participants with unavailable baseline data (2 dyads in the experimental arm) had completed consent and randomization but withdrew before completing baseline questionnaires; their data were therefore excluded from baseline analyses but are included in the participant flow. Baseline N = 58 (experimental) vs 62 (control), total 120.
| Age, Continuous(years) | Experimental: ACP Tabletop Game | Control:ACP Manual | Total |
|---|---|---|---|
| Age (Patients) | 68.6 ± 5.96 | 69.5 ± 6.98 | 69.1 ± 6.46 |
| Age (Surrogates) | 57.8 ± 14.34 | 57.6 ± 11.36 | 57.7 ± 12.78 |
| Sex: Female, Male(Participants) | Experimental: ACP Tabletop Game | Control:ACP Manual | Total |
|---|---|---|---|
| sex (Patients) — Female | 17 | 14 | 31 |
| sex (Patients) — Male | 12 | 17 | 29 |
| sex (Surrogates) — Female | 19 | 20 | 39 |
| sex (Surrogates) — Male | 10 | 11 | 21 |
| Race and Ethnicity Not Collected(Participants) | Experimental: ACP Tabletop Game | Control:ACP Manual | Total |
|---|---|---|---|
| Count of participants | — | — | 0 |
| Education(Participants) | Experimental: ACP Tabletop Game | Control:ACP Manual | Total |
|---|---|---|---|
| Elementary school and below(Patients) | 6 | 9 | 15 |
| High school(Patients) | 13 | 9 | 22 |
| College and above(Patients) | 10 | 13 | 23 |
| Elementary school and below (Surrogates) | 2 | 2 | 4 |
| High school (Surrogates) | 9 | 9 | 18 |
| College and above (Surrogates) | 18 | 20 | 38 |
| Charlson Comorbidity Index (CCI)(index) | Experimental: ACP Tabletop Game | Control:ACP Manual | Total |
|---|---|---|---|
| patient (CCI)Comorbidity index | 8.8 ± 1.53 | 7.9 ± 1.90 | 8.3 ± 1.77 |
| Charlson Comorbidity Index (CCI), surrogates | 2.1 ± 2.55 | 1.4 ± 1.14 | 1.7 ± 1.97 |
| Cancer stage(patients)(Participants) | Experimental: ACP Tabletop Game | Control:ACP Manual | Total |
|---|---|---|---|
| stage I-III | 1 | 7 | 8 |
| stage IV | 28 | 24 | 52 |
| Relationship to patient(surrogates)(Participants) | Experimental: ACP Tabletop Game | Control:ACP Manual | Total |
|---|---|---|---|
| Spouse | 15 | 16 | 31 |
| Adult child | 11 | 13 | 24 |
| Other | 3 | 2 | 5 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided
Ran from Sep 2024 to primary completion in Apr 2025, 7 months.
Results were first posted in Oct 2026, 1 year 6 months after primary completion.
Of 871 non-industry interventional studies with no phase under Lung Neoplasms, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 69. This study's 7 months is below that.
Counting every sponsor, half of 922 studies reached it within 34 months; a quarter within 15 and three quarters within 67.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 30, 2026: primary completion Jul 2025 → Apr 2025 and completion Sep 2025 → Apr 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital →